Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1975 Mar;28(3):244–247. doi: 10.1136/jcp.28.3.244

Tests of thyroid function in vivo.

A W Goolden
PMCID: PMC475670  PMID: 1123452

Full text

PDF
244

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDROS G., HARPER P. V., LATHROP K. A. PERTECHNETATE-99M LOCALIZATION IN MAN WITH APPLICATIONS TO THYROID SCANNING AND THE STUDY OF THYROID PHYSIOLOGY. J Clin Endocrinol Metab. 1965 Aug;25:1067–1076. doi: 10.1210/jcem-25-8-1067. [DOI] [PubMed] [Google Scholar]
  2. Alexander W. D., Harden R. M., Shimmins J., McLarty D., McGill P. Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs. J Clin Endocrinol Metab. 1967 Dec;27(12):1682–1689. doi: 10.1210/jcem-27-12-1682. [DOI] [PubMed] [Google Scholar]
  3. Alexander W. D., Harden R. M., Shimmins J. Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs. Lancet. 1966 Nov 12;2(7472):1041–1044. doi: 10.1016/s0140-6736(66)92024-1. [DOI] [PubMed] [Google Scholar]
  4. Alexander W. D., McLarty D. G., Horton P., Pharmakiotis A. D. Sequential assessment during drug treatment of thyrotoxicosis. Clin Endocrinol (Oxf) 1973 Jan;2(1):43–50. doi: 10.1111/j.1365-2265.1973.tb03483.x. [DOI] [PubMed] [Google Scholar]
  5. Alexander W. D., McLarty D. G., Robertson J., Shimmins J., Brownlie B. E., Harden R. M., Patel A. R. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis. J Clin Endocrinol Metab. 1970 Apr;30(4):540–543. doi: 10.1210/jcem-30-4-540. [DOI] [PubMed] [Google Scholar]
  6. Atkins H. L., Richards P. Assessment of thyroid function and anatomy with technetium-99m as pertechnetate. J Nucl Med. 1968 Jan;9(1):7–15. [PubMed] [Google Scholar]
  7. Burke G., Halko A., Silverstein G. E., Hilligoss M. Comparative thyroid uptake studies with 131 I and 99m TcO 4 - . J Clin Endocrinol Metab. 1972 Apr;34(4):630–637. doi: 10.1210/jcem-34-4-630. [DOI] [PubMed] [Google Scholar]
  8. CASSIDY C. E. USE OF A THYROID SUPPRESSION TEST AS A GUIDE TO PROGNOSIS OF HYPERTHYROIDISM TREATED WITH ANTITHYROID DRUGS. J Clin Endocrinol Metab. 1965 Feb;25:155–156. doi: 10.1210/jcem-25-2-155. [DOI] [PubMed] [Google Scholar]
  9. Glass H. I., Williams E. D., Goolden A. W. A simple, rapid method for measuring the thyroidal uptake of 99 Tc m by profile scanning. Br J Radiol. 1972 Sep;45(537):680–683. doi: 10.1259/0007-1285-45-537-680. [DOI] [PubMed] [Google Scholar]
  10. Goolden A. W., Glass H. I., Silvester D. J. The choice of a radioactive isotope for the investigation of thyroid disorders. Br J Radiol. 1968 Jan;41(481):20–25. doi: 10.1259/0007-1285-41-481-20. [DOI] [PubMed] [Google Scholar]
  11. Goolden A. W., Glass H. I., Williams E. D. Use of 99 Tc m for the routine assessment of thyroid function. Br Med J. 1971 Nov 13;4(5784):396–399. doi: 10.1136/bmj.4.5784.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goolden A. W., Williams E. D., Thalassinos N. C. Studies of thyroid function using 99Tcm in thyrotoxic patients during treatment with antithyroid drugs. Clin Endocrinol (Oxf) 1973 Jan;2(1):65–73. doi: 10.1111/j.1365-2265.1973.tb03486.x. [DOI] [PubMed] [Google Scholar]
  13. Hoff W van't, Pover G. G., Eiser N. M. Technetium-99 m in the diagnosis of thyrotoxicosis. Br Med J. 1972 Oct 28;4(5834):203–206. doi: 10.1136/bmj.4.5834.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hurley P. J., Maisey M. N., Natarajan T. K., Wagner H. N., Jr A computerized system for rapid evaluation of thyroid function. J Clin Endocrinol Metab. 1972 Feb;34(2):354–360. doi: 10.1210/jcem-34-2-354. [DOI] [PubMed] [Google Scholar]
  15. Höschl R., Gimlette T. M. Diagnotic value of 20 minute 99m Tc pertechnetate thyroid uptake. Nucl Med (Stuttg) 1971;10(4):305–315. [PubMed] [Google Scholar]
  16. Lowry R. C., Lowe D., Hadden D. R., Montgomery D. A., Weaver J. A. Thyroid suppressibility: follow-up for two years after antithyroid treatment. Br Med J. 1971 Apr 3;2(5752):19–22. doi: 10.1136/bmj.2.5752.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McGill P. E., Harden R. M., Robertson I. W., Shimmins J. A comparison between the uptake of technetium-99m and iodine-131 by the thyroid gland. J Endocrinol. 1971 Mar;49(3):531–536. doi: 10.1677/joe.0.0490531. [DOI] [PubMed] [Google Scholar]
  18. Shimmins J. G., Harden R. M., Alexander W. D. Loss of pertechnetate from the human thyroid. J Nucl Med. 1969 Oct;10(10):637–640. [PubMed] [Google Scholar]
  19. Shimmins J., Hilditch T., Harden R. M., Alexander W. D. Thyroidal uptake and turnover of the pertechnetate ion in normal and hyperthyroid subjects. J Clin Endocrinol Metab. 1968 Apr;28(4):575–581. doi: 10.1210/jcem-28-4-575. [DOI] [PubMed] [Google Scholar]
  20. Williams E. D., Glass H. I., Goolden A. W., Satyavanich S. Comparison of two methods of measuring the thyroidal uptake of 99m Tc. J Nucl Med. 1972 Feb;13(2):159–162. [PubMed] [Google Scholar]
  21. Williams E. S., Ekins R. P., Ellis S. M. Thyroid stimulation test with serum thyroxine concentration as index of thyroid response. Br Med J. 1969 Nov 8;4(5679):336–338. doi: 10.1136/bmj.4.5679.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Williams E. S., Ekins R. P., Ellis S. M. Thyroid suppression test with serum thyroxine concentration as index of suppression. Br Med J. 1969 Nov 8;4(5679):338–340. doi: 10.1136/bmj.4.5679.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. de Garreta A. C., Fisicas C. S., Glass H. I., Goolden A. W. Measurement of the uptake of 99mTc by the thyroid. Br J Radiol. 1968 Dec;41(492):896–898. doi: 10.1259/0007-1285-41-492-896. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES